col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


181 Results       Page 1

 [1] 
Wiley: Reviews in Medical Virology
  original article Date Title Authors   All Authors
1 [GO] 2023―Mar―21 Biomarkers of endothelial dysfunction are associated with poor outcome in COVID-19 patients: A systematic review and meta-analysis Alireza Mohebbi, Habib Haybar, Fatemeh Nakhaei Moghaddam, Zahra Rasti, Mohammad Amin Vahid, Najmaldin Saki
2 [GO] 2023―Mar―14 The role of corticosteroids may be different in patients with COVID-19 Xiaolu Shao, Qianghong Xu
3 [GO] 2023―Mar―10 Effects of COVID-19 vaccination during pregnancy on SARS-CoV-2 infection and maternal and neonatal outcomes: A systematic review and meta-analysis Masoud Rahmati, Dong Keon Yon, Seung Won Lee, Laurie Butler, Ai Koyanagi, Louis Jacob, et al. (+2)
4 [GO] 2023―Mar―07 Reactivation of herpesviruses during COVID-19: A systematic review and meta-analysis Arman Shafiee, Mohammad Mobin Teymouri Athar, Mohammad Javad Amini, Hamed Hajishah, Sepehr Siahvoshi, Mehrsa Jalali, et al. (+2)
5 [GO] 2023―Feb―18 Prevalence and clinical outcomes of COVID-19 in patients with pre-existing celiac disease: A systematic review and meta-analysis Sawai Singh Rathore, Felipe Velasquez-Botero, María Alejandra Nieto-Salazar, Thomas C. Flowers, Jamal Hasan, Ashwani Kumar Parashar, et al. (+7)
6 [GO] 2023―Feb―18 Cardiac manifestations in children with the multisystem inflammatory syndrome (MIS-C) associated with SARS-CoV-2 infection: Systematic review and meta-analysis Márcio Antonio Ferreira Arantes Junior, Ana Flávia Conegundes, Bárbara Castello Branco Miranda, Alexia Stenner Rodrigues Radicchi Campos, Ana Luiza França Vieira, Matheus Daniel Faleiro, et al. (+3)
7 [GO] 2023―Feb―15 Clinical performance of rapid antigen tests in comparison to RT-PCR for SARS-COV-2 diagnosis in Omicron variant: A systematic review and meta-analysis Zahra Eslami Mohammadie, Saeed Akhlaghi, Saeed Samaeinasab, Shakiba Shaterzadeh-Bojd, Tannaz Jamialahmadi, Amirhossein Sahebkar
8 [GO] 2023―Feb―15 SARS-CoV-2 nucleocapsid: Biological functions and implication for disease diagnosis and vaccine design Faezeh Maghsood, Ahmad Ghorbani, Hamidreza Yadegari, Forough Golsaz-Shirazi, Mohammad Mehdi Amiri, Fazel Shokri
9 [GO] 2023―Feb―15 Human brain organoids to explore SARS-CoV-2-induced effects on the central nervous system Philipp Niklas Ostermann, Heiner Schaal
10 [GO] 2023―Feb―13 Quercetin for the treatment of COVID-19 patients: A systematic review and meta-analysis Huzaifa Ahmad Cheema, Aruba Sohail, Areej Fatima, Abia Shahid, Muhammad Shahzil, Mohammad Ebad Ur Rehman, et al. (+3)
11 [GO] 2023―Feb―02 The immune paradox of SARS-CoV-2: Lymphocytopenia and autoimmunity evoking features in COVID-19 and possible treatment modalities Joachim Gerlach, Abdul Mannan Baig, Mark Fabrowski, Valentina Viduto
12 [GO] 2023―Jan―09 Efficacy and safety of tixagevimab-cilgavimab as pre-exposure prophylaxis for COVID-19: A systematic review and meta-analysis Arto Yuwono Soeroto, Theo Audi Yanto, Andree Kurniawan, Timotius Ivan Hariyanto
13 [GO] 2023―Jan―05 Anakinra was not associated with lower mortality in hospitalised COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials Wenli Shang, Yingying Zhang, Guizuo Wang, Dong Han
14 [GO] 2022―Dec―12 COVID-19 susceptibility and clinical outcomes in inflammatory bowel disease: An updated systematic review and meta-analysis Min Ho Lee, Han Jacob Li, Paul Wasuwanich, Sung Eun Kim, Jong Yeob Kim, Gwang Hun Jeong, et al. (+11)
15 [GO] 2022―Dec―06 Partners in crime: Autoantibodies complicit in COVID-19 pathogenesis Mahdi Taghadosi, Elham Safarzadeh, Ali Asgarzadeh, Seyed Askar Roghani, Afsaneh Shamsi, Cyrus Jalili, et al. (+9)
16 [GO] 2022―Dec―01 B-cell lymphoma-2 family proteins-activated proteases as potential therapeutic targets for influenza A virus and severe acute respiratory syndrome coronavirus-2: Killing two birds with one stone? Sourabh Soni, Yohannes A. Mebratu
17 [GO] 2022―Nov―24 Genetics, structure, transmission, epidemiology, immune response, and vaccine efficacies of the SARS-CoV-2 Delta variant: A comprehensive review Han Li, Chelsea-Jane Arcalas, Junmin Song, Masoud Rahmati, Seoyeon Park, Ai Koyanagi, et al. (+4)
18 [GO] 2022―Nov―08 Insight into the role of clathrin-mediated endocytosis inhibitors in SARS-CoV-2 infection Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Soumya Ghosh, Samah A. Loutfy, Sara Sami ElKaffas, Nasra F. Abdel Fattah, Mohamed Hessien
19 [GO] 2022―Oct―13 Efficacy and safety of sotrovimab in patients with COVID-19: A rapid review and meta-analysis Bahman Amani, Behnam Amani
20 [GO] 2022―Sep―23 SARS-CoV-2 Omicron and its current known unknowns: A narrative review Trang Thi Bich Le, Tamilarasy Vasanthakumaran, Hau Nguyen Thi Hien, I-Chun Hung, Mai Ngoc Luu, Zeeshan Ali Khan, et al. (+7)
21 [GO] 2022―Sep―13 Intravenous immunoglobulin (IVIg) therapy in hospitalised adult COVID-19 patients: A systematic review and meta-analysis Robert Marcec, Vinko Michael Dodig, Igor Radanovic, Robert Likic
22 [GO] 2022―Sep―03 Testosterone and Covid-19: An update Aksam Yassin, Ridwan Sabsigh, Raed M. Al-Zoubi, Omar M. Aboumarzouk, Mustafa Alwani, Joanne Nettleship, Daniel Kelly
23 [GO] 2022―Aug―27 Prognostic value of novel serum biomarkers, including C-reactive protein to albumin ratio and fibrinogen to albumin ratio, in COVID-19 disease: A meta-analysis Sawai Singh Rathore, Sharvi Oberoi, Kinza Iqbal, Keshav Bhattar, Guadalupe Abigail Benítez-López, María Alejandra Nieto-Salazar, et al. (+7)
24 [GO] 2022―Aug―27 Efficacy of tocilizumab in the treatment of COVID-19: An umbrella review Mohammad Mahdi Rezaei Tolzali, Maryam Noori, Pourya Shokri, Shayan Rahmani, Shokoufeh Khanzadeh, Seyed Aria Nejadghaderi, et al. (+6)
25 [GO] 2022―Aug―27 Haemagglutinin, neuraminidase and haemagglutinin esterase on the surface of SARS-CoV-2? Emad Behboudi, Hossein Teimouri
26 [GO] 2022―Aug―27 Response to the letter, entitled ‘Haemagglutinin, neuraminidase and haemagglutinin esterase on the surface of SARS-CoV-2?’ Rania Hamdy, Sameh S. M. Soliman
27 [GO] 2022―Aug―16 Effect of corticosteroid therapy on mortality in COVID-19 patients-A systematic review and meta-analysis Chirag Patel, Krupanshu Parmar, Dipanshi Patel, Sandip Patel, Devang Sheth, Jayesh V. Beladiya
28 [GO] 2022―Jul―20 Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission Lok Bahadur Shrestha, Charles Foster, William Rawlinson, Nicodemus Tedla, Rowena A. Bull
29 [GO] 2022―Jul―12 The association of human leucocyte antigen (HLA) alleles with COVID-19 severity: A systematic review and meta-analysis Zorana Dobrijević, Nikola Gligorijević, Miloš Šunderić, Ana Penezić, Goran Miljuš, Sergej Tomić, Olgica Nedić
30 [GO] 2022―Jun―10 Respiratory viral co-infections in patients with COVID-19 and associated outcomes: A systematic review and meta-analysis Hanna Krumbein, Lara S. Kümmel, Paraskevi C. Fragkou, Clemens Thölken, Ben L. Hünerbein, Rieke Reiter, et al. (+3)
31 [GO] 2022―Jun―04 Recent insights into SARS-CoV-2 omicron variant Severino Jefferson Ribeiro da Silva, Alain Kohl, Lindomar Pena, Keith Pardee
32 [GO] 2022―May―27 The role of cytokines and their antagonists in the treatment of COVID-19 patients Zeinab Mohseni Afshar, Mohammad Barary, Arefeh Babazadeh, Ali Tavakoli Pirzaman, Rezvan Hosseinzadeh, Amirmasoud Alijanpour, et al. (+6)
33 [GO] 2022―May―18 Potential intestinal infection and faecal-oral transmission of human coronaviruses Tingting Ning, Si Liu, Junxuan Xu, Yi Yang, Nan Zhang, Sian Xie, et al. (+4)
34 [GO] 2022―May―02 Recent developments in SARS-CoV-2 vaccines: A systematic review of the current studies Mona Sadeghalvad, Amir Hossein Mansourabadi, Maryam Noori, Seyed Aria Nejadghaderi, Masoomeh Masoomikarimi, Masoumeh Alimohammadi, Nima Rezaei
35 [GO] 2022―Apr―28 Biomarker based biosensors: An opportunity for diagnosis of COVID-19 Reza Khaksarinejad, Zohreh Arabpour, Leila RezaKhani, Farzad Parvizpour, Yousef Rasmi
36 [GO] 2022―Apr―21 Omicron - The new SARS-CoV-2 challenge? A. Lino, M. A. Cardoso, P. Martins-Lopes, H. M. R. Gonçalves
37 [GO] 2022―Apr―13 Development of antibody resistance in emerging mutant strains of SARS CoV-2: Impediment for COVID-19 vaccines Narasimha M. Beeraka, Olga A. Sukocheva, Elena Lukina, Junqi Liu, Ruitai Fan
38 [GO] 2022―Apr―13 Baseline physical activity is associated with reduced mortality and disease outcomes in COVID-19: A systematic review and meta-analysis Masoud Rahmati, Mahdieh Molanouri Shamsi, Kayvan Khoramipour, Fatemeh Malakoutinia, Wongi Woo, Seoyeon Park, et al. (+4)
39 [GO] 2022―Apr―13 Comprehensive adjusted outcome data are needed to assess the impact of immune checkpoint inhibitors in cancer patients with COVID-19: Results of a systematic review and meta-analysis Samuel J. Minkove, Junfeng Sun, Yan Li, Xizhong Cui, Diane Cooper, Peter Q. Eichacker, Parizad Torabi-Parizi
40 [GO] 2022―Apr―13 Muscle dysfunction in the long coronavirus disease 2019 syndrome: Pathogenesis and clinical approach Camilla Costa Silva, Clea Nazaré Carneiro Bichara, Francisca Regina Oliveira Carneiro, Vera Regina da Cunha Menezes Palacios, Ana Virgínia Soares Van den Berg, Juarez Antônio Simões Quaresma, Luiz Fábio Magno Falcão
41 [GO] 2022―Apr―05 Reflections after 2 years of COVID-19 pandemic Daniele Focosi, Arturo Casadevall, Fabrizio Maggi, Guido Antonelli
42 [GO] 2022―Apr―02 Assessing severe acute respiratory syndrome coronavirus 2 infectivity by reverse-transcription polymerase chain reaction: A systematic review and meta-analysis Alexey Fomenko, Stephanie Weibel, Helia Moezi, Kristina Menger, Christine Schmucker, Maria-Inti Metzendorf, et al. (+6)
43 [GO] 2022―Mar―31 Antioxidant/anti-inflammatory effect of Mg 2+ in coronavirus disease 2019 (COVID-19) Yalith Lyzet Arancibia-Hernández, Ana Karina Aranda-Rivera, Alfredo Cruz-Gregorio, José Pedraza-Chaverri
44 [GO] 2022―Mar―29 Effectiveness of rapid antigen testing for screening of asymptomatic individuals to limit the transmission of SARS-CoV-2: A rapid review Kieran A. Walsh, Natasha Broderick, Susan Ahern, Christopher G. Fawsitt, Katie M. O’Brien, Marie Carrigan, et al. (+6)
45 [GO] 2022―Mar―11 Passive immunotherapies for COVID-19: The subtle line between standard and hyperimmune immunoglobulins is getting invisible Daniele Focosi, Massimo Franchini
46 [GO] 2022―Mar―10 Prevalence of oral manifestations in COVID-19: A systematic review Preeti Sharma, Sangeeta Malik, Vijay Wadhwan, Suhasini Gotur Palakshappa, Roli Singh
47 [GO] 2022―Mar―05 COVID-19 outcomes in paediatric cancer: A large scale pooled meta-analysis of 984 cancer patients Amr Ehab El-Qushayri, Amira Yasmine Benmelouka, Abdullah Dahy, Mohammad Rashidul Hashan
48 [GO] 2022―Mar―03 SARS-CoV-2 and dengue virus co-infection: Epidemiology, pathogenesis, diagnosis, treatment, and management Chowdhury Nusaiba Binte Sayed Prapty, Raad Rahmat, Yusha Araf, Samiha Kamal Shounak, Tanjim Ishraq Rahaman, Mohammad Jakir Hosen, et al. (+2)
49 [GO] 2022―Feb―25 Does dengue and COVID-19 co-infection have worse outcomes? A systematic review of current evidence Amr Ehab El-Qushayri, Ahmed Mostafa Ahmed Kamel, Abdullah Reda, Sherief Ghozy
50 [GO] 2022―Feb―09 Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches Mohammad Mahboubi Mehrabani, Mohammad Sobhan Karvandi, Pedram Maafi, Mohammad Doroudian
51 [GO] 2022―Feb―03 SARS-CoV-2-related and Covid-19 vaccine-induced thromboembolic events: A comparative review Zeinab Mohseni Afshar, Mohammad Barary, Arefeh Babazadeh, Rezvan Hosseinzadeh, Amirmasoud Alijanpour, Seyed Rouhollah Miri, et al. (+5)
52 [GO] 2022―Jan―08 Genetic polymorphisms of ACE1 , ACE2 , and TMPRSS2 associated with COVID-19 severity: A systematic review with meta-analysis Wacharapol Saengsiwaritt, Jiraphun Jittikoon, Usa Chaikledkaew, Wanvisa Udomsinprasert
53 [GO] 2022―Jan―06 Great expectations: Living with and not dying from Covid-19 Philip P. Mortimer
54 [GO] 2021―Dec―27 Potential COVID-19 therapeutic approaches targeting angiotensin-converting enzyme 2; An updated review Saba Zanganeh, Nima Goodarzi, Mohammad Doroudian, Elaheh Movahed
55 [GO] 2021―Dec―18 Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series Asra Fazlollahi, Mahdi Zahmatyar, Maryam Noori, Seyed Aria Nejadghaderi, Mark J. M. Sullman, Reza Shekarriz-Foumani, et al. (+3)
56 [GO] 2021―Dec―10 Caution should be exercised when assessing ivermectin for the treatment of COVID-19 in systematic reviews Jiawen Deng, Fangwen Zhou, Kiyan Heybati, Kyra Kavanagh
57 [GO] 2021―Dec―07 Complement inhibition: A possible therapeutic approach in the fight against Covid-19 Niloofar Deravi, Elahe Ahsan, Mobina Fathi, Parastoo Hosseini, Shirin Yaghoobpoor, Ramin Lotfi, et al. (+2)
58 [GO] 2021―Dec―03 Is SARS-CoV-2 viral clearance in nasopharyngeal swabs an appropriate surrogate marker for clinical efficacy of neutralising antibody-based therapeutics? Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, Fabrizio Maggi, Arturo Casadevall
59 [GO] 2021―Nov―10 Covid-19 vaccines and variants of concern: A review Ikbel Hadj Hassine
60 [GO] 2021―Nov―02 Marine mollusc extracts-Potential source of SARS-CoV-2 antivirals Rebecca L. Pedler, Peter G. Speck
61 [GO] 2021―Oct―30 Role of ORF8a as accessory protein in apoptosis induction in SARS-CoV-2 infection Milad Zandi, Hassan Karami
62 [GO] 2021―Oct―29 A comparison with historical influenza prompts better planning for Covid-19 and future pandemics, and gives grounds for optimism Philip Mortimer
63 [GO] 2021―Oct―26 Safety and potency of BIV1-CovIran inactivated vaccine candidate for SARS-CoV-2: A preclinical study Asghar Abdoli, Reza Aalizadeh, Hossein Aminianfar, Zahra Kianmehr, Ali Teimoori, Ebrahim Azimi, et al. (+7)
64 [GO] 2021―Oct―22 Coronavirus disease 2019 (Covid-19) vaccination recommendations in special populations and patients with existing comorbidities Zeinab Mohseni Afshar, Arefeh Babazadeh, Alireza Janbakhsh, Feizollah Mansouri, Terence T. Sio, Mark J. M. Sullman, et al. (+4)
65 [GO] 2021―Oct―21 Hospitalised versus outpatient COVID-19 patients' background characteristics and comorbidities: A systematic review and meta-analysis Paola P. Mattey-Mora, Connor A. Begle, Candice K. Owusu, Chen Chen, Maria A. Parker
66 [GO] 2021―Oct―16 The prevalence, predictors and outcomes of acute liver injury among patients with COVID-19: A systematic review and meta-analysis Harapan Harapan, Jonny Karunia Fajar, Supriono Supriono, Gatot Soegiarto, Laksmi Wulandari, Fiha Seratin, et al. (+25)
67 [GO] 2021―Oct―08 Protection offered by SARS coronavirus 2 vaccines against disease and infection Paul D. Griffiths
68 [GO] 2021―Oct―01 Behaviour of aerosols and their role in the transmission of SARS-CoV-2; a scoping review José Miguel Robles-Romero, Gloria Conde-Guillén, Juan Carlos Safont-Montes, Francisca María García-Padilla, Macarena Romero-Martín
69 [GO] 2021―Sep―30 Cell death mechanisms involved in cell injury caused by SARS-CoV-2 Maríllya Morais da Silva, André Silva Lira de Lucena, Sergio de Sá Leitão Paiva Júnior, Vanessa Mylenna Florêncio De Carvalho, Priscilla Stela Santana de Oliveira, Michelle Melgarejo Rosa, et al. (+3)
70 [GO] 2021―Sep―28 Pharmacological interventions to prevent Covid-19 disease: A rapid review Karen Cardwell, Eamon O Murchu, Paula Byrne, Natasha Broderick, Kieran A. Walsh, Sinéad M. O'Neill, et al. (+4)
71 [GO] 2021―Sep―24 Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients: A systematic review and meta-analysis Jingwen Peng, Meihua Fu, Huan Mei, Hailin Zheng, Guanzhao Liang, Xiaodong She, et al. (+2)
72 [GO] 2021―Sep―21 The Suppressor of Cytokine Signalling family of proteins and their potential impact on COVID-19 disease progression Zheng Yao Low, Ashley Jia Wen Yip, Vincent T. K. Chow, Sunil K. Lal
73 [GO] 2021―Sep―17 Crosstalk between estrogen, dendritic cells, and SARS-CoV-2 infection Daniela Mateus, Ana Isabel Sebastião, Mylène A. Carrascal, Anália do Carmo, Ana Miguel Matos, Maria Teresa Cruz
74 [GO] 2021―Sep―13 Ethnicity as a risk factor for vitamin D deficiency and undesirable COVID-19 outcomes Amir Reza Akbari, Maaz Khan, William Adeboye, Lawrence Hin Hai Lee, Sabbir Islam Chowdhury
75 [GO] 2021―Sep―13 Laboratory biomarkers and prognosis in Covid-19, where do we stand? Alisha Israni, Christopher J. Goulden, Amer Harky
76 [GO] 2021―Sep―09 Long-term side effects and lingering symptoms post COVID-19 recovery Mohammad Zarei, Deepanwita Bose, Masoud Nouri-Vaskeh, Vida Tajiknia, Ramin Zand, Mehdi Ghasemi
77 [GO] 2021―Sep―08 Severe acute respiratory syndrome-2 encodes hemagglutinin esterase? Milad Zandi
78 [GO] 2021―Sep―02 Clinical and laboratory factors associated with coronavirus disease 2019 (Covid-19): A systematic review and meta-analysis Le Huu Nhat Minh, Ali Ahmed-Fouad Abozaid, Nam Xuan Ha, Loc Le Quang, Abdelrahman Gamil Gad, Ranjit Tiwari, et al. (+10)
79 [GO] 2021―Aug―14 Effectiveness of public health measures to prevent the transmission of SARS-CoV-2 at mass gatherings: A rapid review Kieran A. Walsh, Barrie Tyner, Natasha Broderick, Patricia Harrington, Michelle O’Neill, Christopher G. Fawsitt, et al. (+4)
80 [GO] 2021―Aug―07 Mesenchymal stem cells and their derived exosomes to combat Covid-19 Maryam Yousefi Dehbidi, Nima Goodarzi, Mohammad H. Azhdari, Mohammad Doroudian
81 [GO] 2021―Aug―02 Systematic review of host genetic association with Covid-19 prognosis and susceptibility: What have we learned in 2020? João Locke Araújo, Diego Menezes, Julia Maria Saraiva-Duarte, Luciana Ferreira, Renato Aguiar, Renan Souza
82 [GO] 2021―Aug―02 An overview on the seven pathogenic human coronaviruses Mina Mobini Kesheh, Parastoo Hosseini, Saber Soltani, Milad Zandi
83 [GO] 2021―Jul―31 Authors’ response: Ethnicity and vitamin D supplementations for COVID-19 Timotius Ivan Hariyanto, Denny Intan, Joshua Edward Hananto, Harapan Harapan, Andree Kurniawan
84 [GO] 2021―Jul―19 Potency of BNT162b2 and mRNA-1273 vaccine-induced neutralizing antibodies against severe acute respiratory syndrome-CoV-2 variants of concern: A systematic review of in vitro studies Maryam Noori, Seyed Aria Nejadghaderi, Shahnam Arshi, Kristin Carson-Chahhoud, Khalil Ansarin, Ali-Asghar Kolahi, Saeid Safiri
85 [GO] 2021―Jul―14 The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis Amr Ehab El-Qushayri, Sherief Ghozy, Abdullah Reda, Ahmed Mostafa Ahmed Kamel, Alzhraa Salah Abbas, Adam A. Dmytriw
86 [GO] 2021―Jul―10 Hydroxychloroquine in the treatment of coronavirus disease 2019: Rapid updated systematic review and meta-analysis Tejpal Gupta, Prafulla Thakkar, Babusha Kalra, Sadhana Kannan
87 [GO] 2021―Jul―06 Rational procedures for this and the next virus pandemic Philip P Mortimer
88 [GO] 2021―Jul―03 Isothermal amplification-based assays for rapid and sensitive detection of severe acute respiratory syndrome coronavirus 2: Opportunities and recent developments Biswajit Maiti, Karanth Padyana Anupama, Praveen Rai, Indrani Karunasagar, Iddya Karunasagar
89 [GO] 2021―Jul―02 Vaccine-induced immune thrombotic thrombocytopenia after vaccination against Covid-19: A clinical dilemma for clinicians and patients Zeinab Mohseni Afshar, Arefeh Babazadeh, Alireza Janbakhsh, Mandana Afsharian, Kiarash Saleki, Mohammad Barary, Soheil Ebrahimpour
90 [GO] 2021―Jul―01 Persistence of humoral response upon SARS-CoV-2 infection Andrea Knies, Dennis Ladage, Ralf J. Braun, Janine Kimpel, Miriam Schneider
91 [GO] 2021―Jun―27 Vitamin D supplementation and Covid-19 outcomes: A systematic review, meta-analysis and meta-regression Timotius Ivan Hariyanto, Denny Intan, Joshua Edward Hananto, Harapan Harapan, Andree Kurniawan
92 [GO] 2021―Jun―27 Present variants of concern and variants of interest of severe acute respiratory syndrome coronavirus 2: Their significant mutations in S-glycoprotein, infectivity, re-infectivity, immune escape and vaccines activity Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma
93 [GO] 2021―Jun―24 Nanobiosensor-based diagnostic tools in viral infections: Special emphasis on Covid-19 Ranjita Misra, Sarbari Acharya, Nehru Sushmitha
94 [GO] 2021―Jun―07 Ivermectin and outcomes from Covid-19 pneumonia: A systematic review and meta-analysis of randomized clinical trial studies Timotius Ivan Hariyanto, Devina Adella Halim, Jane Rosalind, Catherine Gunawan, Andree Kurniawan
95 [GO] 2021―Jun―07 Role of red blood cell distribution width, as a prognostic indicator in COVID-19: A systematic review and meta-analysis Soumya Sarkar, Sundara Kannan, Puneet Khanna, Akhil Kant Singh
96 [GO] 2021―Jun―03 Epidemiology, prognosis and management of potassium disorders in Covid-19 Maryam Noori, Seyed A. Nejadghaderi, Mark J. M. Sullman, Kristin Carson-Chahhoud, Ali-Asghar Kolahi, Saeid Safiri
97 [GO] 2021―Jun―03 Efficacy and safety of azithromycin in Covid-19 patients: A systematic review and meta-analysis of randomized clinical trials Ahmed M. Kamel, Mona S. A. Monem, Nour A. Sharaf, Nada Magdy, Samar F. Farid
98 [GO] 2021―May―27 Quantifying the risk of SARS-CoV-2 reinfection over time Eamon O Murchu, Paula Byrne, Paul G. Carty, Cillian De Gascun, Mary Keogan, Michelle O’Neill, et al. (+2)
99 [GO] 2021―May―24 Oral manifestations of Covid-19-A literature review Huma Farid, Madiha Khah, Shizrah Jamal, Robia Ghafoor
100 [GO] 2021―May―14 The relationship between blood groups and risk of infection with SARS-CoV-2 or development of severe outcomes: A review Pourya Shokri, Saeid Golmohammadi, Maryam Noori, Seyed Aria Nejadghaderi, Kristin Carson-Chahhoud, Saeid Safiri
101 [GO] 2021―May―14 A rapid review of measures to support people in isolation or quarantine during the Covid-19 pandemic and the effectiveness of such measures Karen Cardwell, Sinéad M. O’Neill, Barrie Tyner, Natasha Broderick, Kirsty O’Brien, Susan M. Smith, et al. (+3)
102 [GO] 2021―Apr―22 Tocilizumab in COVID-19 pneumonia: Practical proposals based on a narrative review of randomised trials Timothée Klopfenstein, Vincent Gendrin, N'dri Juliette Kadiane-Oussou, Thierry Conrozier, Souheil Zayet
103 [GO] 2021―Apr―01 Features of HLA class I expression and its clinical relevance in SARS-CoV-2: What do we know so far? Abdellatif Bouayad
104 [GO] 2021―Mar―25 Review of studies of severe acute respiratory syndrome related coronavirus-2 pathogenesis in human organoid models Ece Egilmezer, William D Rawlinson
105 [GO] 2021―Mar―16 Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines Daniele Focosi, Fabrizio Maggi
106 [GO] 2021―Mar―16 Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus Farzaneh Darbeheshti, Mojdeh Mahdiannasser, Bruce D Uhal, Shuji Ogino, Sudhir Gupta, Nima Rezaei
107 [GO] 2021―Mar―13 Estimating the impact of public health strategies on the spread of SARS-CoV-2: Epidemiological modelling for Toulouse, France Chloé Dimeglio, Marcel Miedougé, Jean-Michel Loubes, Jean-Michel Mansuy, Jacques Izopet
108 [GO] 2021―Mar―05 Vaccines for SARS coronavirus 2 and the new normal in vaccinology P. D. Griffiths
109 [GO] 2021―Mar―01 Sex-based differences in severity and mortality in COVID-19 Mustafa Alwani, Aksam Yassin, Raed M. Al-Zoubi, Omar M. Aboumarzouk, Joanne Nettleship, Daniel Kelly, et al. (+2)
110 [GO] 2021―Mar―01 Covid-19 and oral diseases: Crosstalk, synergy or association? Daniela A. Brandini, Aline S. Takamiya, Pari Thakkar, Samantha Schaller, Rani Rahat, Afsar R. Naqvi
111 [GO] 2021―Feb―23 Current views on the potentials of convalescent plasma therapy (CPT) as Coronavirus disease 2019 (COVID-19) treatment: A systematic review and meta-analysis based on recent studies and previous respiratory pandemics Jenifer Kiem Aviani, Danny Halim, Arto Yuwono Soeroto, Tri Hanggono Achmad, Tono Djuwantono
112 [GO] 2021―Feb―20 C-reactive protein as an effector molecule in Covid-19 pathogenesis Jesús A. Mosquera-Sulbaran, Adriana Pedreañez, Yenddy Carrero, Diana Callejas
113 [GO] 2021―Feb―17 SARS-CoV-2, Covid-19, and the debunking of conspiracy theories Mohamad S. Hakim
114 [GO] 2021―Jan―21 Loop-mediated isothermal amplification (LAMP): An effective molecular point-of-care technique for the rapid diagnosis of coronavirus SARS-CoV-2 Melek Chaouch
115 [GO] 2021―Jan―20 Coronavirus disease 2019 as a syndemic Griffiths Paul
116 [GO] 2021―Jan―15 Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients Mohammad Mahmudur Rahman, Maruf Hasan, Asif Ahmed
117 [GO] 2021―Jan―15 Altered gut microbial metabolites could mediate the effects of risk factors in Covid-19 Jiezhong Chen, Sean Hall, Luis Vitetta
118 [GO] 2021―Jan―15 Lipid-based therapies against SARS-CoV-2 infection Eman Humaid Alketbi, Rania Hamdy, Abdalla El-Kabalawy, Viktorija Juric, Marc Pignitter, Kareem Mosa, et al. (+3)
119 [GO] 2021―Jan―02 Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis Maryamsadat Jafari, Ali Pormohammad, Saeideh Aghayari Sheikh Neshin, Saied Ghorbani, Deepanwita Bose, Shohreh Alimohammadi, et al. (+6)
120 [GO] 2021―Jan―02 How strong is the evidence that it is possible to get SARS-CoV-2 twice? A systematic review Larabe Farrukh, Aqsa Mumtaz, Muhammad K. Sana
121 [GO] 2020―Dec―31 Mega doses of retinol: A possible immunomodulation in Covid-19 illness in resource-limited settings Ish K. Midha, Nilesh Kumar, Amit Kumar, Taruna Madan
122 [GO] 2020―Dec―26 Classical and alternative receptors for SARS-CoV-2 therapeutic strategy Siti Fathiah Masre, Nurul Farhana Jufri, Farah Wahida Ibrahim, Sayyidi Hamzi Abdul Raub
123 [GO] 2020―Dec―25 Background to new treatments for COVID-19, including its chronicity, through altering elements of the cytokine storm Ian A. Clark
124 [GO] 2020―Dec―19 How artificial intelligence may help the Covid-19 pandemic: Pitfalls and lessons for the future Yashpal Singh Malik, Shubhankar Sircar, Sudipta Bhat, Mohd Ikram Ansari, Tripti Pande, Prashant Kumar, et al. (+7)
125 [GO] 2020―Dec―05 Population-based prevalence surveys during the Covid-19 pandemic: A systematic review Vinícius Bonetti Franceschi, Andressa Schneiders Santos, Andressa Barreto Glaeser, Janini Cristina Paiz, Gabriel Dickin Caldana, Carem Luana Machado Lessa, et al. (+7)
126 [GO] 2020―Dec―05 Immunity and inflammatory biomarkers in COVID-19: A systematic review Ana Paula D. Iwamura, Marielen R. Tavares da Silva, Ana Luísa Hümmelgen, Paulo V. Soeiro Pereira, Angela Falcai, Anete Sevciovic Grumach, et al. (+3)
127 [GO] 2020―Nov―21 A systematic meta-analysis of immune signatures in patients with COVID-19 Kun Liu, Tong Yang, Xue-Fang Peng, Shou-Ming Lv, Xiao-lei Ye, Tian-Shuo Zhao, et al. (+5)
128 [GO] 2020―Nov―18 Severe acute respiratory syndrome coronavirus-2 natural animal reservoirs and experimental models: systematic review Salma Younes, Nadin Younes, Farah Shurrab, Gheyath K. Nasrallah
129 [GO] 2020―Nov―18 Pharmacogenomics of genetic polymorphism within the genes responsible for SARS-CoV-2 susceptibility and the drug-metabolising genes used in treatment Laith N. AL-Eitan, Saif Z. Alahmad
130 [GO] 2020―Nov―11 Impact of COVID-19 on polio vaccination in Pakistan: a concise overview Misbahud Din, Hammad Ali, Mudassir Khan, Abdul Waris, Sana Ullah, Muhammad Kashif, et al. (+2)
131 [GO] 2020―Nov―07 The effectiveness of non-contact thermal screening as a means of identifying cases of Covid-19: a rapid review of the evidence Karen Cardwell, Karen Jordan, Paula Byrne, Susan M. Smith, Patricia Harrington, Mairin Ryan, Michelle O'Neill
132 [GO] 2020―Nov―05 Diagnostic accuracy of serological tests and kinetics of severe acute respiratory syndrome coronavirus 2 antibody: A systematic review and meta-analysis Daniel Mekonnen, Hylemariam Mihiretie Mengist, Awoke Derbie, Endalkachew Nibret, Abaineh Munshea, Hongliang He, et al. (+2)
133 [GO] 2020―Oct―31 Intricate interplay between Covid-19 and cardiovascular diseases Vishakh C. Keri, Amit Hooda, Parul Kodan, Brunda R L, Pankaj Jorwal, Naveet Wig
134 [GO] 2020―Oct―31 Efficacy and safety of remdesivir in hospitalized Covid-19 patients: Systematic review and meta-analysis including network meta-analysis Hozaifa Khalil Elsawah, Mohamed Ahmed Elsokary, Mahmoud Samy Abdallah, Ahmed Hanei ElShafie
135 [GO] 2020―Oct―26 YouTube as a source of patient information for Covid-19: An enhanced content-quality and audience engagement analysis Wajahat Mughal, Zahid Mohammed, Abdullah Zafar, Benyamin Alam
136 [GO] 2020―Oct―26 Airborne transmission of SARS-CoV-2 via aerosols Laura Comber, Eamon O Murchu, Linda Drummond, Paul G. Carty, Kieran A. Walsh, Cillian F. De Gascun, et al. (+5)
137 [GO] 2020―Oct―22 Alternative clinical specimens for the detection of SARS-CoV-2: A rapid review Laura Comber, Kieran A. Walsh, Karen Jordan, Kirsty K. O'Brien, Barbara Clyne, Conor Teljeur, et al. (+7)
138 [GO] 2020―Oct―15 Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects Arash Arashkia, Somayeh Jalilvand, Nasir Mohajel, Atefeh Afchangi, Kayhan Azadmanesh, Mostafa Salehi-Vaziri, et al. (+6)
139 [GO] 2020―Oct―09 Comparison of influenza type A and B with COVID-19: A global systematic review and meta-analysis on clinical, laboratory and radiographic findings Ali Pormohammad, Saied Ghorbani, Alireza Khatami, Mohammad Hossein Razizadeh, Ehsan Alborzi, Mohammad Zarei, et al. (+2)
140 [GO] 2020―Oct―06 Covid-19 and kidney injury: Pathophysiology and molecular mechanisms Elham Ahmadian, Seyed Mahdi Hosseiniyan Khatibi, Saiedeh Razi Soofiyani, Sima Abediazar, Mohammadali M. Shoja, Mohammadreza Ardalan, Sepideh Zununi Vahed
141 [GO] 2020―Oct―06 Anticoagulation outcomes in hospitalized Covid-19 patients: A systematic review and meta-analysis of case-control and cohort studies Ahmed M. Kamel, Mona Sobhy, Nada Magdy, Nirmeen Sabry, Samar Farid
142 [GO] 2020―Oct―06 Clotting disorder in severe acute respiratory syndrome coronavirus 2 Sujit Pujhari, Sanjeeta Paul, Jasmina Ahluwalia, Jason L. Rasgon
143 [GO] 2020―Oct―01 Is there light at the end of the Covid-19 tunnel? Philip P. Mortimer
144 [GO] 2020―Sep―25 The complexity of respiratory disease associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: From immunopathogenesis to respiratory therapy Luiz Fábio Falcão, Lucieny da Silva Pontes, Bruno Giovanni Afonso da Silva, Karen Margarete Vieira da Silva Franco, Luiz Adriano Costa, Rodrigo Santiago Barbosa Rocha, Juarez Antônio Simões Quaresma
145 [GO] 2020―Sep―23 Immune response following infection with SARS-CoV -2 and other coronaviruses: A rapid review Eamon O Murchu, Paula Byrne, Kieran A. Walsh, Paul G. Carty, Máire Connolly, Cillian De Gascun, et al. (+8)
146 [GO] 2020―Sep―23 Severe acute respiratory syndrome-coronavirus-2: Current advances in therapeutic targets and drug development Sakthivel Suganya, Suresh Divya, Madasamy Parani
147 [GO] 2020―Sep―22 Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker? Jing Liu, Salim S. Virani, Mahboob Alam, Ali E. Denktas, Ihab Hamzeh, Umair Khalid
148 [GO] 2020―Sep―22 Viral infection neutralization tests: A focus on severe acute respiratory syndrome-coronavirus-2 with implications for convalescent plasma therapy Daniele Focosi, Fabrizio Maggi, Paola Mazzetti, Mauro Pistello
149 [GO] 2020―Sep―21 Transplantation in the era of the Covid-19 pandemic: How should transplant patients and programs be handled? Mohamed M. NasrAllah, Noha A. Osman, Mahmoud Elalfy, Paolo Malvezzi, Lionel Rostaing
150 [GO] 2020―Sep―19 The unique features of SARS-CoV-2 transmission: Comparison with SARS-CoV, MERS-CoV and 2009 H1N1 pandemic influenza virus Zhonglan Wu, David Harrich, Zhongyang Li, Dongsheng Hu, Dongsheng Li
151 [GO] 2020―Sep―18 Covid-19 and dengue: Double punches for dengue-endemic countries in Asia Harapan Harapan, Mirza Ryan, Benediktus Yohan, Rufika Shari Abidin, Firzan Nainu, Ahmed Rakib, et al. (+6)
152 [GO] 2020―Sep―18 Investigation of immune cells on elimination of pulmonary-Infected COVID-19 and important role of innate immunity, phagocytes Esmaeil Farshi, Bahram Kasmapur, Anya Arad
153 [GO] 2020―Sep―16 SARS-CoV-2: Mechanism of infection and emerging technologies for future prospects Shiqin Li, Sijia Li, Cyrollah Disoma, Rong Zheng, Mei Zhou, Aroona Razzaq, et al. (+10)
154 [GO] 2020―Sep―02 Interleukin-6 in Covid-19: A systematic review and meta-analysis Eric A. Coomes, Hourmazd Haghbayan
155 [GO] 2020―Sep―02 SARS-CoV -2 infection in people living with HIV : a systematic review Paola Costenaro, Chiara Minotti, Elisa Barbieri, Carlo Giaquinto, Daniele Donà
156 [GO] 2020―Aug―28 Vitamin D and Covid-19: From potential therapeutic effects to unanswered questions Majid Teymoori-Rad, Sayed Mahdi Marashi
157 [GO] 2020―Aug―28 Comparative analysis of the genome structure and organization of the Middle East respiratory syndrome coronavirus ( MERS-CoV ) 2012 to 2019 revealing evidence for virus strain barcoding, zoonotic transmission, and selection pressure Mohamed M. Ba Abduallah, Maged Gomaa Hemida
158 [GO] 2020―Aug―28 SARS-CoV : Lessons learned; opportunities missed for SARS-CoV -2 Ian M. Davis
159 [GO] 2020―Aug―26 Alpha-1-antitrypsin : A possible host protective factor against Covid-19 Mariana Braccialli Loyola, Thaís Tereza Aguiar Reis, Guilherme Xavier Lyra Malcher Oliveira, Julys Fonseca Palmeira, Gustavo A. Argañaraz, Enrique R. Argañaraz
160 [GO] 2020―Aug―11 Drugs against SARS-CoV -2: What do we know about their mode of action? Coralie Valle, Baptiste Martin, Franck Touret, Ashleigh Shannon, Bruno Canard, Jean-Claude Guillemot, et al. (+2)
161 [GO] 2020―Aug―05 Review: An insight into coronaviruses: Challenges, security and scope Niyati Shah, Vipul Davariya, Sanjeev K. Gupta, Pankaj Gajjar, Jitendra Parmar, Lancelot D'Cruz
162 [GO] 2020―Jul―31 Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV Abdellatif Bouayad
163 [GO] 2020―Jul―28 Toward better pandemic planning: An urgent priority Philip P. Mortimer
164 [GO] 2020―Jul―20 Novel coronavirus SARS-CoV -2 (Covid-19) dynamics inside the human body Asit Saha, Barsha Saha
165 [GO] 2020―Jul―20 Neuropathogenic human coronaviruses: A review Osama S. Abdelaziz, Zuraiha Waffa
166 [GO] 2020―Jul―13 Lessons from dermatology about inflammatory responses in Covid-19 Paulo Ricardo Criado, Carla Pagliari, Francisca Regina Oliveira Carneiro, Juarez Antonio Simões Quaresma
167 [GO] 2020―Jul―10 Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection Synat Keam, Dewi Megawati, Shailesh Kumar Patel, Ruchi Tiwari, Kuldeep Dhama, Harapan Harapan
168 [GO] 2020―Jul―09 Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review Richard A. Giovane, Shadi Rezai, Ellen Cleland, Cassandra E. Henderson
169 [GO] 2020―Jul―03 Covid-19: Time for a paradigm change Franco M. Buonaguro, Paolo A. Ascierto, Gene D. Morse, Luigi Buonaguro, Igor Puzanov, Maria Lina Tornesello, et al. (+2)
170 [GO] 2020―Jul―02 Using heat to kill SARS-CoV -2 John P. Abraham, Brian D. Plourde, Lijing Cheng
171 [GO] 2020―Jun―30 Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection Heng Wee Tan, Yan-Ming Xu, Andy T. Y. Lau
172 [GO] 2020―Jun―15 YouTube as a source of patient information for Coronavirus Disease ( COVID -19): A content-quality and audience engagement analysis Tomasz Szmuda, Mohammad Talha Syed, Akshita Singh, Shan Ali, Cathrine Özdemir, Paweł Słoniewski
173 [GO] 2020―Jun―04 Emergence of novel coronavirus and progress toward treatment and vaccine Muhammad Muzamil Khan, Amna Noor, Asadullah Madni*, Mudassir Shafiq
174 [GO] 2020―May―20 The basic reproduction number of SARS-CoV-2 in Wuhan is about to die out, how about the rest of the World? Bootan Rahman, Evar Sadraddin, Annamaria Porreca
175 [GO] 2020―May―13 SARS coronavirus 2; how many more examples do we need before the world commits to decisive action? P. D. Griffiths
176 [GO] 2020―May―12 The 2019 human coronavirus: Ten areas of uncertainty waiting to be resolved Philip P. Mortimer
177 [GO] 2020―Apr―21 Melatonin: Roles in influenza, Covid-19, and other viral infections George Anderson, Russel J. Reiter
178 [GO] 2020―Apr―17 Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures Ying Yan, Le Chang, Lunan Wang
179 [GO] 2020―Apr―08 Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS Mohsen Rokni, Vida Ghasemi, Zahra Tavakoli
180 [GO] 2020―Mar―16 Clinical features of deaths in the novel coronavirus epidemic in China Char Leung
181 [GO] 2020―Mar―05 Pandemic potential of highly pathogenic avian influenza clade 2.3.4.4 A(H5) viruses Reina Yamaji, Magdi D. Saad, Charles T. Davis, David E. Swayne, Dayan Wang, Frank Y.K. Wong, et al. (+6)
 [1] 

181 Results       Page 1


[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.005 sec